Marco A. Velasco‐Velázquez

Author

Universidad Nacional Autónoma de México ORCID

Also Known As

M VELASCOVELAZQUEZ, M Velasco-Velzquez, M Velasco-Velázquez, M Velazquez, M. A. Velasco-Velázquez, M. Velasco-Velazquez, M. Velazquez, MA Velasco-Velázquez, MA. Velasco-Velázquez, Marco Antonio Velasco-Velázquez

182

Publications

3.4K

Citations

H-Index

106

Concepts

All Affiliations

Universidad Nacional Autónoma de México Instituto Politécnico Nacional Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz University of Groningen Institute for Social Security and Services for State Workers

About

Marco A. Velasco‐Velázquez is an author at Universidad Nacional Autónoma de México specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1K
2	Engineering	3	3	68
3	Natural Sciences	3	3	61
4	Health Sciences	2	2	82
5	Public Health	1	1	29

Marco A. Velasco‐Velázquez

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells Marco A. Velasco‐Velázquez, Xuanmao Jiao, Marisol De La Fuente, Cancer Research Breast OncologyImmunologyImmune Checkpoint InhibitorBreast CancerCancer Treatment	2012	277
IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients Danelia Mendieta, Dora Luz de la Cruz-Aguilera, María Isabel Barrera-Villalpando, Journal of Neuroimmunology InflammationAnti-inflammatoryPain MedicineImmunologyInflammatory Response	2015	156
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion Xuanmao Jiao, Marco A. Velasco‐Velázquez, Min Wang, Cancer Research	2018	124
4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16?F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility Marco A. Velasco‐Velázquez Cancer Letters MechanobiologyCell AdhesionActin CytoskeletonMolecular BiologyMatrix Proteins	2003	95
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics Rick Oerlemans, Angel J. Ruiz‐Moreno, Yingying Cong, RSC Medicinal Chemistry	2020	82
CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene–Transformed Metastatic Prostate Cancer Cell Lines Daniela Sicoli, Xuanmao Jiao, Xiaoming Ju, Cancer Research	2014	77
Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions María de Lourdes Mora‐García, Rosario García‐Rocha, Omar Morales-Ramírez, Journal of Translational Medicine	2016	73
The CCL5/CCR5 axis promotes metastasis in basal breast cancer Marco A. Velasco‐Velázquez, Richard G. Pestell OncoImmunology Breast OncologyOncologyBasal Breast CancerMedicineCcl5/ccr5 Axis	2013	70
NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer Karla Vázquez-Santillán, Jorge Meléndez-Zajgla, Luis Jimenez-Hernandez, Scientific Reports Transcriptional RegulationBreast OncologyQuantitative Rt-pcrMedicineStem Cells	2016	70
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin Fausto Alejandro Jiménez-Orozco, José Sullivan López-González, Alejandro Nieto, Lung Cancer Tumor BiologyOncogenic AgentCyclin D1MedicinePharmacology	2001	61

Page 1